Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

[1]  I. McKeith,et al.  Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation , 2006, Neurobiology of Disease.

[2]  E. Giacobini,et al.  The Brain Cholinergic System , 2006 .

[3]  S. Wonnacott,et al.  Indirect Modulation by α7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal , 2006, Molecular Pharmacology.

[4]  F. Leslie,et al.  Enhanced nicotinic acetylcholine receptor-mediated [3H]norepinephrine release from neonatal rat hypothalamus , 2006, Neuropharmacology.

[5]  C. Gotti,et al.  Brain neuronal nicotinic receptors as new targets for drug discovery. , 2006, Current pharmaceutical design.

[6]  F. Huethe,et al.  Dopamine release in human neocortical slices: Characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release , 2006, Brain Research Bulletin.

[7]  F. Joseph McClernon,et al.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization , 2006, Psychopharmacology.

[8]  S. Di Angelantonio,et al.  Long‐term exposure to the new nicotinic antagonist 1,2‐bisN‐cytisinylethane upregulates nicotinic receptor subtypes of SH‐SY5Y human neuroblastoma cells , 2005, British journal of pharmacology.

[9]  K. Kellar,et al.  Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes , 2005, Molecular Pharmacology.

[10]  Y. Yanagawa,et al.  Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus. , 2005, Journal of neurophysiology.

[11]  P. Taylor,et al.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations , 2005, The EMBO journal.

[12]  K. Kellar,et al.  Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes , 2005, The Journal of Neuroscience.

[13]  T. Liljefors,et al.  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. , 2005, Journal of medicinal chemistry.

[14]  J. Changeux,et al.  Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype α3β2(α5 or β3) Enriched in Retinocollicular Afferents , 2005, Molecular Pharmacology.

[15]  T. Sixma,et al.  Crystal Structure of Acetylcholine-binding Protein from Bulinus truncatus Reveals the Conserved Structural Scaffold and Sites of Variation in Nicotinic Acetylcholine Receptors* , 2005, Journal of Biological Chemistry.

[16]  Jayanta Mukherjee,et al.  Structural Determinants of α4β2 Nicotinic Acetylcholine Receptor Trafficking , 2005, The Journal of Neuroscience.

[17]  J. Changeux,et al.  Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors , 2005, Nature.

[18]  I. Jones,et al.  Presynaptic α7 and non-α7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro , 2005, Neuropharmacology.

[19]  I. Jones,et al.  Why doesn't nicotinic ACh receptor immunoreactivity knock out? , 2005, Trends in Neurosciences.

[20]  J. Changeux,et al.  Allosteric Mechanisms of Signal Transduction , 2005, Science.

[21]  A. C. Collins,et al.  Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene Deletion , 2005, Molecular Pharmacology.

[22]  J. Changeux,et al.  Nicotine Upregulates Its Own Receptors through Enhanced Intracellular Maturation , 2005, Neuron.

[23]  C. Surowy,et al.  Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus , 2005, Journal of Pharmacology and Experimental Therapeutics.

[24]  C. Surowy,et al.  Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release , 2005, Neuropharmacology.

[25]  J. McIntosh,et al.  α-Conotoxin BuIA, a Novel Peptide from Conus bullatus, Distinguishes among Neuronal Nicotinic Acetylcholine Receptors* , 2005, Journal of Biological Chemistry.

[26]  C. Gotti,et al.  Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA , 2005, Molecular Pharmacology.

[27]  J. Lindstrom,et al.  Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. , 2005, Molecular pharmacology.

[28]  A. C. Collins,et al.  Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. , 2005, Molecular pharmacology.

[29]  C. Gotti,et al.  Neuronal nicotinic receptors: from structure to pathology , 2004, Progress in Neurobiology.

[30]  E. Severance,et al.  Distribution and synaptic localization of nicotinic acetylcholine receptors containing a novel α7 subunit isoform in embryonic rat cortical neurons , 2004, Neuroscience Letters.

[31]  L. Rojas,et al.  Nicotine-induced Up-regulation and Desensitization of α4β2 Neuronal Nicotinic Receptors Depend on Subunit Ratio* , 2004, Journal of Biological Chemistry.

[32]  M. Quik.  Smoking, nicotine and Parkinson's disease , 2004, Trends in Neurosciences.

[33]  M. Zoli,et al.  Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. , 2004, Molecular pharmacology.

[34]  S. Wonnacott,et al.  Nicotinic acetylcholine receptors and the regulation of neuronal signalling. , 2004, Trends in pharmacological sciences.

[35]  A. C. Collins,et al.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. , 2004, Molecular pharmacology.

[36]  K. Kellar,et al.  Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. , 2004, Bioorganic & medicinal chemistry letters.

[37]  E. Perry,et al.  Molecular analysis of nicotinic receptor expression in autism. , 2004, Brain research. Molecular brain research.

[38]  Michael J. Marks,et al.  Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors , 2004 .

[39]  D Bertrand,et al.  Nicotinic acetylcholine receptors as drug targets. , 2004, Current drug targets. CNS and neurological disorders.

[40]  T. Sixma,et al.  Nicotine and Carbamylcholine Binding to Nicotinic Acetylcholine Receptors as Studied in AChBP Crystal Structures , 2004, Neuron.

[41]  Paul Newhouse,et al.  Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. , 2003, Current topics in medicinal chemistry.

[42]  T Baldwinson,et al.  Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. , 2003, Current topics in medicinal chemistry.

[43]  J. Changeux,et al.  Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. , 2002, Progress in brain research.

[44]  S. Vicini,et al.  The nicotinic receptor in the rat pineal gland is an alpha3beta4 subtype. , 2004, Molecular pharmacology.

[45]  Carol Brayne,et al.  Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. , 2004, Neuroscience letters.

[46]  A. C. Collins,et al.  The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors , 2003, The Journal of Neuroscience.

[47]  K. Davis,et al.  Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia , 2003, Biological Psychiatry.

[48]  Jon M. Lindstrom,et al.  α-Conotoxin PIA Is Selective for α6 Subunit-Containing Nicotinic Acetylcholine Receptors , 2003, The Journal of Neuroscience.

[49]  Nicolas Le Novère,et al.  Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice , 2003, The Journal of Neuroscience.

[50]  M. Horne,et al.  Neuronal nicotinic receptors: insights gained from gene knockout an knocking mutant mice , 2003, Cellular and Molecular Life Sciences CMLS.

[51]  H. Schröder,et al.  Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients , 2003 .

[52]  R. Longhi,et al.  Developmental expression of heteromeric nicotinic receptor subtypes in chick retina. , 2003, Molecular pharmacology.

[53]  J. Lindstrom,et al.  Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine Receptors , 2003 .

[54]  E. Perry,et al.  Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes , 2003, Glia.

[55]  D. Bertrand,et al.  Nicotinic acetylcholine receptors: from structure to brain function. , 2003, Reviews of physiology, biochemistry and pharmacology.

[56]  J. Lindstrom,et al.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. , 2003, Molecular pharmacology.

[57]  M. Picciotto,et al.  Nicotinic receptors in aging and dementia. , 2002, Journal of neurobiology.

[58]  J. Changeux,et al.  The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. , 2002, Journal of neurobiology.

[59]  M. Zoli,et al.  Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum , 2002, The Journal of Neuroscience.

[60]  J. Changeux,et al.  Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system. , 2002, Current drug targets. CNS and neurological disorders.

[61]  D. Sheehan,et al.  Nicotinic acetylcholine receptors as targets for antidepressants , 2002, Molecular Psychiatry.

[62]  C Martin-Ruiz,et al.  Nicotinic receptor abnormalities in the cerebellar cortex in autism. , 2002, Brain : a journal of neurology.

[63]  A. C. Collins,et al.  Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. , 2002, The Journal of pharmacology and experimental therapeutics.

[64]  B. Millet,et al.  Prevalence of smoking in psychiatric patients , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65]  A. C. Collins,et al.  Involvement of the α3 Subunit in Central Nicotinic Binding Populations , 2002, The Journal of Neuroscience.

[66]  F. Leslie,et al.  Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons , 2002, The Journal of comparative neurology.

[67]  D. Sheehan,et al.  Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine , 2002, Depression and anxiety.

[68]  D. Brunzell,et al.  Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. , 2001, Pharmacology & therapeutics.

[69]  E K Perry,et al.  Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. , 2001, The American journal of psychiatry.

[70]  R. Longhi,et al.  An α4β4 nicotinic receptor subtype is present in chick retina: Identification, characterization and pharmacological comparison with the transfected α4β4 and α6β4 subtypes , 2001 .

[71]  Michele Zoli,et al.  Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei , 2001, The Journal of Neuroscience.

[72]  Carmen Martin-Ruiz,et al.  Nicotinic receptor abnormalities in Alzheimer’s disease , 2001, Biological Psychiatry.

[73]  R. Longhi,et al.  An a 4 b 4 Nicotinic Receptor Subtype Is Present in Chick Retina: Identification, Characterization and Pharmacological Comparison with the Transfected a 4 b 4 and a 6 b 4 Subtypes , 2001 .

[74]  A. C. Collins,et al.  Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia , 2000, Neuropsychopharmacology.

[75]  J. Changeux,et al.  Localization of nAChR subunit mRNAs in the brain of Macaca mulatta , 2000, The European journal of neuroscience.

[76]  C. Gotti,et al.  Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype , 2000 .

[77]  P. Newhouse,et al.  The effects of nicotine on Parkinson's disease. , 2000, Brain and cognition.

[78]  E. Perry,et al.  Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication , 2000, Neuroscience.

[79]  J. Lindstrom.  The Structures of Neuronal Nicotinic Receptors , 2000 .

[80]  E. Perry,et al.  Involvement of Neuronal Nicotinic Receptors in Disease , 2000 .

[81]  J. Changeux,et al.  Nicotinic receptors at the amino acid level. , 2000, Annual review of pharmacology and toxicology.

[82]  C. Gotti,et al.  Chick Optic Lobe Contains a Developmentally Regulated a 2 a 5 b 2 Nicotinic Receptor Subtype 1 , 2000 .

[83]  R. Longhi,et al.  Functional α6-Containing Nicotinic Receptors Are Present in Chick Retina , 1999 .

[84]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[85]  D. K. Berg,et al.  Nicotinic Receptor Subtypes in the Developing Chick Brain: Appearance of a Species Containing the α4, β2, and α5 Gene Products , 1998 .

[86]  R. Longhi,et al.  α7 and α8 Nicotinic Receptor Subtypes Immunopurified from Chick Retina have Different Immunological, Pharmacological and Functional Properties , 1997 .

[87]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[88]  P. Sanberg,et al.  Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.

[89]  J. Changeux,et al.  Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat Brain , 1996, The European journal of neuroscience.

[90]  D. Yoshikami,et al.  A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*) , 1996, The Journal of Biological Chemistry.

[91]  R Freedman,et al.  Nicotinic receptor function in schizophrenia. , 1996, Schizophrenia bulletin.

[92]  D. Bertrand,et al.  Pharmacology and Biophysical Properties of α7 and α7 ‐ α8 α‐Bungarotoxin Receptor Subtypes Immunopurified from the Chick Optic Lobe , 1994 .

[93]  R Anand,et al.  Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. , 1994, Molecular pharmacology.

[94]  G. Barrantes.  Nicotinic acetylcholine receptor subtypes in primary cultures of hippocampal neurons , 1994 .